Arbutus Biopharma Corporation (ABUS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.34
Day's range
$4.8

Arbutus Biopharma Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TWO SEAS CAPITAL LP 08/12/2026 19.10 M $91.66 M   2.90% 9.85%
MORGAN STANLEY 08/13/2026 17.70 M $84.95 M   -31.64% 9.13%
WHITEFORT CAPITAL MANAGEMENT, LP 08/14/2026 15.79 M $75.81 M   5.78% 8.15%
BLACKROCK, INC. 08/07/2026 13.77 M $66.08 M   6.16% 7.10%
STATE STREET CORP 08/07/2026 7.87 M $37.77 M   24.07% 4.06%
RUBRIC CAPITAL MANAGEMENT LP 08/14/2026 7.53 M $36.16 M   13.68% 3.89%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 7.01 M $33.65 M   4.81% 3.62%
BARCLAYS PLC 08/14/2026 4.21 M $20.20 M   -2.51% 2.17%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 4.12 M $19.77 M   9.17% 2.13%
GOLDMAN SACHS GROUP INC 08/14/2026 3.51 M $16.83 M   218.67% 1.81%
BANK OF AMERICA CORP /DE/ 08/14/2026 2.65 M $12.70 M   57.17% 1.37%
BLACKBARN CAPITAL PARTNERS LP 08/14/2026 2.50 M $12.00 M   0.00% 1.29%
LEGAL & GENERAL GROUP PLC 08/14/2026 2.47 M $11.84 M   2.70% 1.27%
WOODLINE PARTNERS LP 08/14/2026 2.28 M $10.95 M   13.52% 1.18%
JEFFERIES FINANCIAL GROUP INC. 08/17/2026 1.71 M $8.22 M   -9.63% 0.88%
NOMURA HOLDINGS INC 08/14/2026 1.64 M $7.86 M   100.00% 0.84%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.54 M $7.40 M   10.74% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.43 M $6.87 M   2.15% 0.74%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.43 M $6.87 M   100.00% 0.74%
NORTHERN TRUST CORP 08/13/2026 1.42 M $6.81 M   11.05% 0.73%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 1.35 M $6.47 M   -0.02% 0.70%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 1.27 M $6.09 M   -59.53% 0.65%
DELTROIT ASSET MANAGEMENT (UK) LLP 08/14/2026 1.20 M $5.76 M   50.00% 0.62%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.14 M $5.45 M   6.80% 0.59%
CITIGROUP INC 08/03/2026 879.24 K $4.22 M   -2.14% 0.45%
BANK OF MONTREAL /CAN/ 08/12/2026 777.94 K $3.73 M   -0.62% 0.40%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 650.70 K $3.12 M   100.00% 0.34%
MACKENZIE FINANCIAL CORP 08/13/2026 613.81 K $2.95 M   100.00% 0.32%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/13/2026 602.01 K $2.89 M   100.00% 0.31%
JUPITER TOPCO LLC 08/14/2026 597.42 K $2.87 M   100.00% 0.31%
WESTERN STANDARD LLC 08/10/2026 542.79 K $2.61 M   4.06% 0.28%
RANGELEY CAPITAL, LLC 08/14/2026 500.00 K $2.40 M   0.00% 0.26%
NUVEEN, LLC 08/11/2026 496.61 K $2.38 M   91.73% 0.26%
MAN GROUP PLC 08/14/2026 473.47 K $2.27 M   100.00% 0.24%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 461.65 K $2.22 M   4.70% 0.24%
BANK OF NEW YORK MELLON CORP 08/06/2026 454.12 K $2.18 M   19.70% 0.23%
CENTERBOOK PARTNERS LP 08/11/2026 445.15 K $2.14 M   100.00% 0.23%
FREESTONE CAPITAL HOLDINGS, LLC 07/31/2026 442.50 K $2.12 M   0.00% 0.23%
CITADEL ADVISORS LLC 08/14/2026 404.70 K $1.94 M   -40.23% 0.21%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 385.30 K $1.85 M   -1.99% 0.20%
D. E. SHAW & CO., INC. 08/14/2026 381.86 K $1.83 M   166.66% 0.20%
SWISS NATIONAL BANK 08/11/2026 286.50 K $1.38 M   1.09% 0.15%
LEDGEWOOD WEALTH ADVISORS, LLC 07/08/2026 278.44 K $1.34 M   0.00% 0.14%
FMR LLC 08/13/2026 267.19 K $1.28 M   84.11% 0.14%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 263.69 K $1.27 M   1,301.09% 0.14%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 261.05 K $1.25 M   -68.86% 0.13%
CARRERA CAPITAL ADVISORS 08/03/2026 257.17 K $1.23 M   1.99% 0.13%
QUINN OPPORTUNITY PARTNERS LLC 08/14/2026 255.21 K $1.23 M   -50.40% 0.13%
INVESCO LTD. 08/14/2026 250.91 K $1.20 M   1.20% 0.13%
UBS GROUP AG 08/13/2026 249.21 K $1.20 M   -31.62% 0.13%

Arbutus Biopharma Corp institutional Ownership - FAQ's

During the previous two years, 238 institutional investors and hedge funds held shares of Arbutus Biopharma Corp. The most heavily invested institutionals were:

Two Seas Capital LP: 19.1 M

MORGAN STANLEY: 17.7 M

Whitefort Capital Management, LP: 15.79 M

BlackRock, Inc.: 13.77 M

STATE STREET CORP: 7.87 M

Rubric Capital Management LP: 7.53 M

73.19% of Arbutus Biopharma Corp stock is owned by institutional investors.

Institutional investors have bought a total of 166.49 M shares in the last 24 months. This purchase volume represents approximately $785.84 M in transactions.